Scholars Central

Review articlePublished 15 Jul 2016

Insulin resistance in major depressive disorder and the effects of psychotropic medications

Authors: Jennifer S Mason, Heather A Kenna, Natalie L Rasgon

Clinical Practice

Volume 9 · Issue 5 · Pages 579

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Major depression is a serious medical condition with an estimated lifetime prevalence rate of 16.6% (32.6–35.1 million) within the USA. High comorbidity exists between major depression and chronic medical conditions, such as Type 2 diabetes, cardiovascular disease and polycystic ovary syndrome. These diseases are, in turn, pathophysiologically linked by a metabolic state of insulin resistance, characterized by hyperinsulinemia, hyperlipidemia and often overweight/obesity. Many common psychiatric medications, such as antidepressants, anticonvulsants and antipsychotics, used in the treatment of major depression are associated with metabolic dysfunction indicative of insulin resistance. This article provides a review of data specific to major depression and insulin resistance, discusses shared healthrelated problems seen in both conditions, and examines adverse side effects of antidepressant and antipsychotic medications used to treat depression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Practice
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Jennifer S Mason”
  • BylineArticles whose byline prints “Heather A Kenna”
  • BylineArticles whose byline prints “Natalie L Rasgon”